norfloxacin has been researched along with Burns in 11 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Burns: Injuries to tissues caused by contact with heat, steam, chemicals (BURNS, CHEMICAL), electricity (BURNS, ELECTRIC), or the like.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Compared with non-burned subjects, burn patients exhibit a shorter elimination half-life, but modifications in dosage regimen are not required." | 1.27 | [Pharmacokinetics of pefloxacin in burn patients]. ( Baron, D; Drugeon, HB; Meignier, M; Montay, G; Potel, G; Touzé, MD, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 7 (63.64) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dave, V | 1 |
| Kushwaha, K | 1 |
| Yadav, RB | 1 |
| Agrawal, U | 1 |
| Modak, SM | 1 |
| Fox, CL | 1 |
| Boyce, ST | 1 |
| Warden, GD | 1 |
| Holder, IA | 1 |
| Liu, LL | 1 |
| Cheng, M | 1 |
| Gao, S | 1 |
| Huo, ZL | 1 |
| Liao, WZ | 1 |
| Pandey, S | 1 |
| Basheer, M | 1 |
| Roy, S | 1 |
| Udupa, N | 1 |
| Jia, CY | 1 |
| Wang, DW | 1 |
| Ge, SD | 1 |
| Potel, G | 1 |
| Meignier, M | 1 |
| Touzé, MD | 1 |
| Montay, G | 1 |
| Drugeon, HB | 1 |
| Baron, D | 1 |
1 review available for norfloxacin and Burns
| Article | Year |
|---|---|
[Prospects of clinical uses of quinolones in burn wound infections].
Topics: Animals; Anti-Infective Agents; Burns; Ciprofloxacin; Humans; Norfloxacin; Wound Infection | 1990 |
10 other studies available for norfloxacin and Burns
| Article | Year |
|---|---|
Hybrid nanoparticles for the topical delivery of norfloxacin for the effective treatment of bacterial infection produced after burn.
Topics: Animals; Bacterial Infections; Burns; Calorimetry, Differential Scanning; Drug Carriers; Microbial S | 2017 |
Sulfadiazine silver-resistant Pseudomonas in Burns. New topical agents.
Topics: Administration, Topical; Animals; Burns; Drug Resistance, Microbial; Female; In Vitro Techniques; Mi | 1981 |
Noncytotoxic combinations of topical antimicrobial agents for use with cultured skin substitutes.
Topics: Administration, Topical; Amphotericin B; Burns; Candida; Cells, Cultured; Ciprofloxacin; Culture Tec | 1995 |
[Determination of norfloxacin, an active dissociation product of silver norfloxacin, in guinea pig plasma and tissue by high performance liquid chromatography with column-switching].
Topics: Administration, Topical; Animals; Anti-Infective Agents; Anti-Infective Agents, Local; Burns; Fluoro | 1994 |
[Comparison of topical therapeutic effect between silver norfloxacin (Ag-NFL) and silver sulfadiazine (Ag-SD) in treatment of pyocyaneous sepsis in burn rats].
Topics: Administration, Topical; Animals; Anti-Infective Agents; Burns; Female; Fluoroquinolones; Male; Norf | 1993 |
[Bacteriostatic effects of silver norfloxacin, silver sulfadiazine, and "moisture burn ointment"].
Topics: Burns; Drugs, Chinese Herbal; Escherichia coli; Humans; Microbial Sensitivity Tests; Norfloxacin; Ps | 1993 |
Development and evaluation of transdermal formulations containing metronidazole and norfloxacin for the treatment of burn wound.
Topics: Administration, Cutaneous; Animals; Burns; Male; Metronidazole; Norfloxacin; Rats; Rats, Wistar | 1999 |
[Drug resistance and floral distribution of Pseudomonas aeruginosa].
Topics: Amikacin; Burns; Ceftazidime; Cross Infection; Drug Resistance, Microbial; Female; Humans; Middle Ag | 1990 |
[The effect of pyridonic acid derivatives as topical antibiotics on the prevention and treatment of pyocyaneous infection following burn].
Topics: Administration, Topical; Animals; Burns; Male; Mice; Norfloxacin; Pseudomonas Infections; Rabbits; S | 1987 |
[Pharmacokinetics of pefloxacin in burn patients].
Topics: Adult; Analysis of Variance; Anti-Infective Agents; Burns; Half-Life; Humans; Infusions, Intravenous | 1987 |